InsiderTrades.com logo

KALV Insider Trading

Insider Ownership Percentage: 4.30%
Insider Buying (Last 12 Months): $235,500.00
Insider Selling (Last 12 Months): $1,773,180.51

KalVista Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at KalVista Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

KalVista Pharmaceuticals Share Price & Price History

Current Price: $14.91
Price Change: ▼ Price Decrease of -0.21 (-1.39%)
As of 02/13/2026 05:00 PM ET

This chart shows the closing price history over time for KALV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

KalVista Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/12/2026Benjamin L. PalleikoCEOSell3,354$15.70$52,657.80428,286View SEC Filing Icon  
12/8/2025Benjamin L. PalleikoCEOSell7,294$16.51$120,423.94424,520View SEC Filing Icon  
11/24/2025Benjamin L. PalleikoCEOSell10,940$13.45$147,143.00416,189View SEC Filing Icon  
11/24/2025Brian PiekosCFOSell4,471$13.45$60,134.9510,529View SEC Filing Icon  
11/24/2025Paul K. AudhyaInsiderSell5,296$13.45$71,231.20131,831View SEC Filing Icon  
11/12/2025Benjamin L. PalleikoCEOSell3,328$11.55$38,438.40398,981View SEC Filing Icon  
9/8/2025Benjamin L. PalleikoCEOSell7,294$15.84$115,536.96395,189View SEC Filing Icon  
8/25/2025Nicole SweenyInsiderSell1,480$13.42$19,861.6032,291View SEC Filing Icon  
8/25/2025Paul K. AudhyaInsiderSell2,336$13.42$31,349.12122,505View SEC Filing Icon  
8/22/2025Benjamin L. PalleikoCEOSell10,940$13.22$144,626.80386,858View SEC Filing Icon  
8/22/2025Nicole SweenyInsiderSell1,864$13.22$24,642.0828,771View SEC Filing Icon  
8/22/2025Paul K. AudhyaInsiderSell2,942$13.22$38,893.24119,841View SEC Filing Icon  
7/9/2025Benjamin L. PalleikoCEOSell32,979$15.69$517,440.51369,595View SEC Filing Icon  
6/9/2025Benjamin L. PalleikoCEOSell7,169$14.50$103,950.50315,074View SEC Filing Icon  
5/23/2025Paul K. AudhyaInsiderSell2,146$11.31$24,271.26113,026View SEC Filing Icon  
5/19/2025Benjamin L. PalleikoCEOSell3,808$11.84$45,086.72293,367View SEC Filing Icon  
5/19/2025Paul K. AudhyaInsiderSell2,776$11.84$32,867.84106,611View SEC Filing Icon  
4/9/2025Venrock Healthcare Capital ParMajor ShareholderBuy25,000$9.42$235,500.005,303,985View SEC Filing Icon  
3/7/2025Benjamin L. PalleikoCEOSell6,669$11.97$79,827.93287,811View SEC Filing Icon  
2/24/2025Paul K. AudhyaInsiderSell2,394$10.02$23,987.88102,940View SEC Filing Icon  
2/18/2025Benjamin L. PalleikoCEOSell5,104$9.82$50,121.28278,855View SEC Filing Icon  
2/18/2025Paul K. AudhyaInsiderSell3,125$9.82$30,687.50100,334View SEC Filing Icon  
2/12/2025Venrock Healthcare Capital ParMajor ShareholderBuy100,000$9.23$923,000.005,217,285View SEC Filing Icon  
2/10/2025Venrock Healthcare Capital ParMajor ShareholderBuy4,137$9.14$37,812.185,090,582View SEC Filing Icon  
2/7/2025Venrock Healthcare Capital ParMajor ShareholderBuy73,649$9.29$684,199.215,086,445View SEC Filing Icon  
2/3/2025Venrock Healthcare Capital ParMajor ShareholderBuy14,562$9.22$134,261.645,012,796View SEC Filing Icon  
1/30/2025Venrock Healthcare Capital ParMajor ShareholderBuy43,707$8.76$382,873.324,986,480View SEC Filing Icon  
12/9/2024Benjamin L. PalleikoCEOSell7,627$9.75$74,363.25274,596View SEC Filing Icon  
11/26/2024Paul K. AudhyaInsiderSell2,187$9.87$21,585.6997,012View SEC Filing Icon  
11/18/2024Benjamin L. PalleikoCEOSell14,400$9.26$133,344.00266,598View SEC Filing Icon  
11/18/2024Paul K. AudhyaInsiderSell8,077$9.26$74,793.0294,199View SEC Filing Icon  
9/9/2024Benjamin L. PalleikoCEOSell7,352$12.19$89,620.88250,800View SEC Filing Icon  
8/23/2024Paul K. AudhyaInsiderSell2,135$12.40$26,474.0083,745View SEC Filing Icon  
8/19/2024Benjamin L. PalleikoCEOSell14,215$12.01$170,722.15242,527View SEC Filing Icon  
8/19/2024Christopher YeaInsiderSell7,102$12.01$85,295.0284,467View SEC Filing Icon  
6/7/2024Benjamin L. PalleikoCEOSell7,465$11.53$86,071.45224,547View SEC Filing Icon  
5/20/2024Benjamin L. PalleikoCEOSell21,959$11.76$258,237.84216,387View SEC Filing Icon  
5/20/2024Edward P. FeenerInsiderSell8,088$11.76$95,114.8872,858View SEC Filing Icon  
2/20/2024Benjamin L. PalleikoCFOSell22,802$14.11$321,736.22187,315View SEC Filing Icon  
2/20/2024Edward P. FeenerInsiderSell28,288$14.07$398,012.1662,157View SEC Filing Icon  
2/20/2024Thomas Andrew CrockettCEOSell24,888$14.11$351,169.68211,203View SEC Filing Icon  
2/8/2024Venrock Healthcare Capital ParMajor ShareholderBuy29,747$14.70$437,280.904,824,731View SEC Filing Icon  
2/6/2024Venrock Healthcare Capital ParMajor ShareholderBuy4,474$14.74$65,946.764,743,157View SEC Filing Icon  
1/29/2024Venrock Healthcare Capital ParMajor ShareholderBuy80,600$14.22$1,146,132.004,650,584View SEC Filing Icon  
1/26/2024Venrock Healthcare Capital ParMajor ShareholderBuy4,174$12.98$54,178.524,569,984View SEC Filing Icon  
1/24/2024Venrock Healthcare Capital ParMajor ShareholderBuy20,686$12.44$257,333.844,558,780View SEC Filing Icon  
1/22/2024Venrock Healthcare Capital ParMajor ShareholderBuy67,546$12.55$847,702.304,527,197View SEC Filing Icon  
1/18/2024Venrock Healthcare Capital ParMajor ShareholderBuy39,680$12.51$496,396.804,434,651View SEC Filing Icon  
1/16/2024Venrock Healthcare Capital ParMajor ShareholderBuy19,599$12.73$249,495.274,316,046View SEC Filing Icon  
1/11/2024Edward P. FeenerInsiderSell22,679$13.03$295,507.3739,828View SEC Filing Icon  
1/10/2024Venrock Healthcare Capital ParMajor ShareholderBuy47,700$12.67$604,359.004,289,800View SEC Filing Icon  
1/8/2024Edward P. FeenerInsiderSell17,221$13.01$224,045.2162,607View SEC Filing Icon  
1/8/2024Venrock Healthcare Capital ParMajor ShareholderBuy69,184$12.44$860,648.964,221,284View SEC Filing Icon  
1/3/2024Venrock Healthcare Capital ParMajor ShareholderBuy17,605$12.20$214,781.004,110,336View SEC Filing Icon  
12/29/2023Venrock Healthcare Capital ParMajor ShareholderBuy6,013$12.49$75,102.374,092,731View SEC Filing Icon  
12/27/2023Thomas Andrew CrockettCEOSell30,000$12.02$360,600.00127,532View SEC Filing Icon  
12/27/2023Venrock Healthcare Capital ParMajor ShareholderBuy41,514$11.97$496,922.583,615,228View SEC Filing Icon  
9/11/2023Albert ChaDirectorSell18,000$10.50$189,000.00View SEC Filing Icon  
8/18/2023Benjamin L. PalleikoCFOSell13,067$10.73$140,208.9195,254View SEC Filing Icon  
8/18/2023Paul K. AudhyaInsiderSell8,020$10.73$86,054.6026,023View SEC Filing Icon  
8/18/2023Thomas Andrew CrockettCEOSell14,876$10.73$159,619.48146,756View SEC Filing Icon  
5/18/2023Benjamin L. PalleikoCFOSell4,037$10.14$40,935.1878,126View SEC Filing Icon  
5/18/2023Christopher YeaInsiderSell2,604$10.14$26,404.5637,310View SEC Filing Icon  
5/18/2023Thomas Andrew CrockettCEOSell5,627$10.14$57,057.78128,050View SEC Filing Icon  
2/17/2023Benjamin L. PalleikoCFOSell4,954$7.66$37,947.6472,799View SEC Filing Icon  
2/17/2023Paul K. AudhyaInsiderSell3,412$7.66$26,135.929,347View SEC Filing Icon  
2/17/2023Thomas Andrew CrockettCEOSell6,700$7.66$51,322.00120,927View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for KalVista Pharmaceuticals (NASDAQ:KALV)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at KALV by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

KalVista Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2026The Manufacturers Life Insurance Company 11,823$0.19M0.0%-11.0%0.023%Search for SEC Filing on Google Icon
2/13/2026Schroder Investment Management Group1,171,755$18.92M0.0%+1.1%2.318%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC65,593$1.06M0.0%+13.5%0.130%Search for SEC Filing on Google Icon
2/13/2026Birchview Capital LP57,000$0.92M0.5%-14.9%0.113%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.324,369$5.24M0.0%+0.7%0.642%Search for SEC Filing on Google Icon
2/13/2026State Street Corp1,911,691$30.87M0.0%+21.3%3.782%Search for SEC Filing on Google Icon
2/13/2026Martingale Asset Management L P30,939$0.50M0.0%N/A0.061%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC27,722$0.45M0.0%+103.8%0.055%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN56,014$0.91M0.0%+50.4%0.111%Search for SEC Filing on Google Icon
2/12/2026HRT Financial LP287,052$4.64M0.0%N/A0.568%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC165,151$2.67M0.0%N/A0.327%Search for SEC Filing on Google Icon
2/12/2026Skandinaviska Enskilda Banken AB publ 351,305$5.68M0.0%+74.8%0.695%Search for SEC Filing on Google Icon
2/12/2026Alps Advisors Inc.41,504$0.67M0.0%N/A0.082%Search for SEC Filing on Google Icon
2/12/2026Swiss National Bank54,900$0.89M0.0%+13.2%0.109%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC107,129$1.73M0.0%+34.3%0.212%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG35,091$0.57M0.0%+16.0%0.069%Search for SEC Filing on Google Icon
2/11/2026Capital World Investors2,808,583$45.36M0.0%-11.6%5.556%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.835,304$13.49M0.0%-53.6%1.652%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC944,077$15.25M0.0%+1.7%1.868%Search for SEC Filing on Google Icon
2/9/2026Bleakley Financial Group LLC15,976$0.26M0.0%N/A0.032%Search for SEC Filing on Google Icon
2/9/2026Blue Owl Capital Holdings LP360,000$5.81M0.4%+188.0%0.712%Search for SEC Filing on Google Icon
2/6/2026Rathbones Group PLC12,272$0.20M0.0%-33.4%0.024%Search for SEC Filing on Google Icon
2/3/2026F m Investments LLC236,690$3.82M0.1%+18.8%0.468%Search for SEC Filing on Google Icon
2/2/2026Cerro Pacific Wealth Advisors LLC10,000$0.16M0.0%N/A0.020%Search for SEC Filing on Google Icon
1/29/2026UBS Group AG371,993$6.01M0.0%-18.1%0.736%Search for SEC Filing on Google Icon
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank 17,868$0.29M0.0%+293.1%0.035%Search for SEC Filing on Google Icon
1/21/2026Rathbones Group PLC12,272$0.20M0.0%-33.4%0.024%Search for SEC Filing on Google Icon
1/14/2026Hennion & Walsh Asset Management Inc.341,819$5.52M0.2%+93.6%0.676%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC48,030$0.78M0.0%+15.4%0.095%Search for SEC Filing on Google Icon
1/9/2026Diversified Trust Co.10,870$0.18M0.0%N/A0.022%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.20,759$0.25M0.0%-10.6%0.041%Search for SEC Filing on Google Icon
12/9/2025Tudor Investment Corp ET AL2,000,000$24.36M0.0%N/A3.956%Search for SEC Filing on Google Icon
11/17/2025Vestal Point Capital LP750,000$9.14M0.4%-84.0%1.484%Search for SEC Filing on Google Icon
11/17/2025Susquehanna Fundamental Investments LLC10,686$0.13M0.0%-63.0%0.021%Search for SEC Filing on Google Icon
11/17/2025Sherbrooke Park Advisers LLC15,678$0.19M0.1%N/A0.031%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd325,435$3.96M0.0%+234.6%0.644%Search for SEC Filing on Google Icon
11/17/2025Parkman Healthcare Partners LLC1,735,003$21.13M2.2%+155.5%3.433%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.20,512$0.25M0.0%-10.7%0.041%Search for SEC Filing on Google Icon
11/17/2025Boxer Capital Management LLC20,400$0.25M0.1%-78.2%0.040%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP55,878$0.68M0.0%+319.1%0.111%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE364,409$4.44M0.0%-0.7%0.721%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.35,449$0.43M0.0%-96.2%0.070%Search for SEC Filing on Google Icon
11/14/2025Creative Planning38,032$0.46M0.0%+13.9%0.075%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC446,372$5.44M0.0%+207.2%0.884%Search for SEC Filing on Google Icon
11/14/2025SummitTX Capital L.P.143,561$1.75M0.1%N/A0.284%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.149,306$1.82M0.0%+47.8%0.296%Search for SEC Filing on Google Icon
11/14/2025Freestone Grove Partners LP704,448$8.58M0.1%N/A1.394%Search for SEC Filing on Google Icon
11/14/2025Zurcher Kantonalbank Zurich Cantonalbank 4,545$55K0.0%N/A0.009%Search for SEC Filing on Google Icon
11/14/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC13,600$0.17M0.0%N/A0.027%Search for SEC Filing on Google Icon
11/14/2025Suvretta Capital Management LLC4,768,712$58.08M1.5%-3.8%9.439%Search for SEC Filing on Google Icon
11/14/2025F m Investments LLC199,204$2.43M0.1%+9.3%0.394%Search for SEC Filing on Google Icon
11/13/2025Sei Investments Co.11,896$0.15M0.0%N/A0.024%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG454,148$5.53M0.0%+66.4%0.899%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets7,794$95K0.0%+92.9%0.015%Search for SEC Filing on Google Icon
11/13/2025Magnetar Financial LLC26,924$0.33M0.0%N/A0.053%Search for SEC Filing on Google Icon
11/13/2025Legal & General Group Plc23,954$0.29M0.0%+470.1%0.047%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.56,196$0.68M0.0%+5.9%0.111%Search for SEC Filing on Google Icon
11/13/2025Schroder Investment Management Group1,158,457$14.15M0.0%+108.7%2.293%Search for SEC Filing on Google Icon
11/13/2025Jefferies Financial Group Inc.286,875$3.49M0.0%N/A0.568%Search for SEC Filing on Google Icon
11/13/2025Blue Owl Capital Holdings LP125,000$1.52M0.5%N/A0.247%Search for SEC Filing on Google Icon
11/12/2025Barclays PLC577,904$7.04M0.0%+242.1%1.144%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP45,444$0.55M0.0%-73.8%0.090%Search for SEC Filing on Google Icon
11/12/2025Rafferty Asset Management LLC57,790$0.70M0.0%+23.2%0.114%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC12,919$0.16M0.0%-26.9%0.026%Search for SEC Filing on Google Icon
11/10/2025AXQ Capital LP17,213$0.21M0.1%N/A0.034%Search for SEC Filing on Google Icon
11/10/2025Citigroup Inc.280,656$3.42M0.0%-6.2%0.556%Search for SEC Filing on Google Icon
11/10/2025China Universal Asset Management Co. Ltd.8,824$0.11M0.0%-11.6%0.017%Search for SEC Filing on Google Icon
11/7/2025Skandinaviska Enskilda Banken AB publ 200,991$2.45M0.0%+391.9%0.398%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.2,501,119$30.46M0.0%+3.7%4.950%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.20,759$0.25M0.0%-10.6%0.041%Search for SEC Filing on Google Icon
11/6/2025Rhumbline Advisers52,798$0.64M0.0%-2.9%0.105%Search for SEC Filing on Google Icon
11/6/2025Profund Advisors LLC12,613$0.15M0.0%+25.9%0.025%Search for SEC Filing on Google Icon
11/5/2025Savant Capital LLC11,568$0.14M0.0%N/A0.023%Search for SEC Filing on Google Icon
11/3/2025AlphaQuest LLC51,775$0.63M0.0%+39,422.9%0.102%Search for SEC Filing on Google Icon
10/30/2025Emerald Mutual Fund Advisers Trust917,975$11.18M0.6%+19.4%1.817%Search for SEC Filing on Google Icon
10/30/2025Emerald Advisers LLC1,351,254$16.46M0.5%+30.2%2.675%Search for SEC Filing on Google Icon
10/28/2025Wolverine Asset Management LLC4,662$57K0.0%N/A0.009%Search for SEC Filing on Google Icon
10/23/2025SG Americas Securities LLC41,620$0.51M0.0%N/A0.082%Search for SEC Filing on Google Icon
10/23/2025KLP Kapitalforvaltning AS5,200$63K0.0%N/A0.010%Search for SEC Filing on Google Icon
10/22/2025Hennion & Walsh Asset Management Inc.176,583$2.15M0.1%+13.2%0.350%Search for SEC Filing on Google Icon
9/4/2025Osaic Holdings Inc.21,915$0.25M0.0%N/A0.044%Search for SEC Filing on Google Icon
8/15/2025Tower Research Capital LLC TRC 8,059$91K0.0%+816.8%0.016%Search for SEC Filing on Google Icon
8/15/2025Vestal Point Capital LP4,675,000$52.85M2.8%-1.6%9.359%Search for SEC Filing on Google Icon
8/15/2025Rafferty Asset Management LLC46,901$0.53M0.0%+78.5%0.094%Search for SEC Filing on Google Icon
8/15/2025Rosalind Advisors Inc.157,725$1.78M0.8%-48.1%0.316%Search for SEC Filing on Google Icon
8/15/2025Octagon Capital Advisors LP1,273,333$14.40M3.2%-7.1%2.549%Search for SEC Filing on Google Icon
8/15/2025BNP Paribas Financial Markets4,041$46K0.0%+47.0%0.008%Search for SEC Filing on Google Icon
8/15/2025Brevan Howard Capital Management LP13,333$0.15M0.0%N/A0.027%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE366,966$4.15M0.0%+19.0%0.735%Search for SEC Filing on Google Icon
8/15/2025Ameriprise Financial Inc.945,125$10.69M0.0%+2,258.6%1.892%Search for SEC Filing on Google Icon
8/14/2025Raymond James Financial Inc.101,035$1.14M0.0%N/A0.202%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.22,964$0.26M0.0%-5.6%0.046%Search for SEC Filing on Google Icon
8/14/2025The Manufacturers Life Insurance Company 14,626$0.17M0.0%+5.9%0.029%Search for SEC Filing on Google Icon
8/14/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC79,460$0.90M0.0%-53.2%0.159%Search for SEC Filing on Google Icon
8/14/2025Stempoint Capital LP386,790$4.37M1.4%-20.6%0.774%Search for SEC Filing on Google Icon
8/14/2025Qube Research & Technologies Ltd97,248$1.10M0.0%N/A0.195%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP119,622$1.35M0.0%+47.7%0.239%Search for SEC Filing on Google Icon
8/13/2025Stonepine Capital Management LLC100,000$1.13M1.1%+364.0%0.200%Search for SEC Filing on Google Icon
8/13/2025Saturn V Capital Management LP62,793$0.71M0.3%-75.4%0.126%Search for SEC Filing on Google Icon
8/13/2025Invesco Ltd.50,761$0.57M0.0%+27.5%0.102%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
KalVista Pharmaceuticals logo
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company's product candidate is Sebetralstat, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE). It develops Factor XIIa, an oral inhibitor for the treatment of HAE which is in preclinical trial. In addition, the company is developing an orally disintegrating tablet formulation, including KONFIDENT-KID for pediatric use with HAE; KONFIDENT-S for adolescent and adult patients with type I or type II HAE; and KONFIDENT for a potential oral therapy for HAE attacks. The company is headquartered in Cambridge, Massachusetts.
Read More on KalVista Pharmaceuticals

Today's Range

Now: $14.91
Low: $14.81
High: $15.42

50 Day Range

MA: $15.63
Low: $14.40
High: $16.91

52 Week Range

Now: $14.91
Low: $9.23
High: $19.00

Volume

527,886 shs

Average Volume

734,306 shs

Market Capitalization

$753.70 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of KalVista Pharmaceuticals?

KalVista Pharmaceuticals' top insider investors include:
  1. Venrock Healthcare Capital Par (Major Shareholder)
  2. Benjamin L Palleiko (CEO)
  3. Thomas Andrew Crockett (CEO)
  4. Benjamin L Palleiko (CFO)
  5. Paul K Audhya (Insider)
  6. Christopher Yea (Insider)
  7. Edward P Feener (Insider)
  8. Nicole Sweeny (Insider)
  9. Brian Piekos (CFO)
Learn More about top insider investors at KalVista Pharmaceuticals.

Who are the major institutional investors of KalVista Pharmaceuticals?

KalVista Pharmaceuticals' top institutional shareholders include:
  1. Capital World Investors — 5.56%
  2. State Street Corp — 3.78%
  3. Schroder Investment Management Group — 2.32%
  4. Geode Capital Management LLC — 1.87%
  5. Goldman Sachs Group Inc. — 1.65%
  6. UBS Group AG — 0.74%
Learn More about top institutional investors of KalVista Pharmaceuticals stock.

Which institutional investors are selling KalVista Pharmaceuticals stock?

In the last quarter, KALV stock was sold by these institutional investors:
  1. Goldman Sachs Group Inc.
  2. Capital World Investors
  3. UBS Group AG
  4. Birchview Capital LP
  5. Rathbones Group PLC
  6. Rathbones Group PLC
  7. The Manufacturers Life Insurance Company
  8. Simplex Trading LLC
Within the previous year, company insiders that have sold KalVista Pharmaceuticals company stock include:
  1. Venrock Healthcare Capital Par (Major Shareholder)
  2. Benjamin L Palleiko (CEO)
  3. Thomas Andrew Crockett (CEO)
  4. Benjamin L Palleiko (CFO)
Learn More investors selling KalVista Pharmaceuticals stock.

Which institutional investors are buying KalVista Pharmaceuticals stock?

During the previous quarter, KALV stock was purchased by institutional investors including:
  1. State Street Corp
  2. HRT Financial LP
  3. Blue Owl Capital Holdings LP
  4. Hennion & Walsh Asset Management Inc.
  5. Renaissance Technologies LLC
  6. Skandinaviska Enskilda Banken AB publ
  7. Alps Advisors Inc.
  8. F m Investments LLC